Colon CancerNIMANCT07534852
NIMA-Colon Cancer Study
A study testing Standard hypercaloric-hyperproteic nutritional supplementation, HMB-enriched hypercaloric-hyperproteic nutritional supplementation with vitamin D and calcium and Supervised exercise program in people with Colon Cancer, run by Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud at 1 site in Spain.
Trial summary
The goal of this study is to evaluate the effects of nutritional supplementation and physical activity interventions on recovery, muscle strength, nutritional status, inflammation, and metabolic health in adults with colon cancer undergoing surgery. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Colon Cancer
- What is being tested?
- Standard hypercaloric-hyperproteic nutritional supplementation, HMB-enriched hypercaloric-hyperproteic nutritional supplementation with vitamin D and calcium and Supervised exercise program
- Type of treatment
- Pill or oral medicine, Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteSpain
- Study dates
- 1 Jul 2025to Dec 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults aged 18 to 75 years.
- Male and female participants.
- Diagnosis of colon cancer at localized or locally advanced stages (TNM stages I-III).
- Patients scheduled for primary surgical treatment.
Who cannot join
- Metastatic disease (stage IV)
- Diagnosis of rectal cancer or tumors involving the rectum
- Prior neoadjuvant chemotherapy or radiotherapy before surgery.
- Presence of synchronous malignant tumors.
- Pregnant or breastfeeding women.
- Presence of severe medical conditions, including acute pancreatitis, severe liver or kidney disease, heart failure, severe pulmonary disease, or peripheral arterial disease affecting the lower limbs.
Show all 11Show fewer
- Diagnosis of anorexia nervosa or other severe eating disorders.
- Known allergy or intolerance to any nutritional supplements used in the study.
- Medical contraindications to moderate-to-vigorous physical activity.
- Regular participation in high-intensity exercise programs.
- High risk of poor adherence to the study procedures, as determined by the study team.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Spain1 site, 1 recruiting
- Recruiting
Hospital Universitario Virgen de la Victoria
Málaga, Malaga, 29010
Manuel Macías Gonzalez, PhD., +34 952 36 76 00, mmaciasmanuel@gmail.com
Libia Alejandra Garcia-Flores, PhD., +34 952 36 76 00, libia.garcia@ibima.eu
About this study
Official title: Nutritional, Inflammatory, and Muscular Assessment (NIMA) in Patients With Colon Cancer
The goal of this study is to evaluate the effects of nutritional supplementation and physical activity interventions on recovery, muscle strength, nutritional status, inflammation, and metabolic health in adults with colon cancer undergoing surgery.
Patients with colon cancer frequently experience loss of muscle mass, reduced physical function, and nutritional deterioration both before and after surgery, which may adversely affect recovery and quality of life.
Read more
A key objective of this study is to assess whether a postoperative intervention combining nutritional supplementation with beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, together with a structured physical activity program, can improve muscle strength and functional recovery following colon cancer surgery.
This study aims to answer the following questions:
- Does nutritional supplementation with HMB and vitamin D, combined with postoperative physical activity, improve muscle strength and physical function following colon cancer surgery?
- How do nutritional and lifestyle interventions influence nutritional status, gut microbiota composition, and biological markers of inflammation and metabolism during the recovery period?
- Are there differences in recovery outcomes between patients receiving different types of nutritional support, with or without supervised physical activity?
Participants will be adults diagnosed with colon cancer who undergo surgical treatment at the Hospital Universitario Virgen de la Victoria in Málaga, Spain. Patients will be recruited prior to surgery and will enter a prehabilitation phase integrated into routine care provided by the Endocrinology and Nutrition Department.
During this prehabilitation phase, nutritional status will be assessed and optimized using standard clinical care, including oral nutritional supplementation when indicated. The aim is to improve the patient's condition before surgery. Approximately one month after surgery, once initial postoperative recovery has been completed, participants will enter the intervention and assessment phase (baseline visit).
Participants will then be randomly assigned to one of four study groups in a 2×2 factorial design. These groups combine two nutritional strategies (standard care or supplementation with HMB and vitamin D) and two physical activity approaches (supervised exercise or general activity recommendations). The physical activity component, supervised by the Endocrinology and Nutrition team, will be objectively evaluated using an accelerometer-based device. Participants will be followed for approximately six months, with assessments at about 3 and 6 months after the baseline visit.
At each visit, participants will undergo:
- Body composition measurements
- Muscle strength and physical performance tests
- Collection of blood, urine, and stool samples
- Questionnaires on health status and quality of life
The results of this study will contribute to a more profound understanding of how tailored nutritional strategies and postoperative physical activity may support recovery and functional health in patients undergoing surgery for colon cancer.
Read the detailed description
Colon cancer patients frequently present with nutritional impairment, systemic inflammation, and early loss of muscle mass even before surgical treatment. These conditions may be exacerbated by surgical stress, reduced intake, and postoperative physical inactivity, leading to delayed recovery, functional decline, and impaired quality of life. Interventions targeting nutritional and functional status across the perioperative period may help improve physiological reserve and support postoperative recovery.
The NIMA study (Nutritional, Inflammatory, and Muscular Assessment) is designed to evaluate the impact of perioperative nutritional care and postoperative physical activity strategies on recovery, muscle strength, nutritional status, inflammation, metabolic health, and gut microbiota in adults undergoing surgery for colon cancer. The study combines routine preoperative nutritional management with a structured postoperative intervention and follow-up period, allowing assessment of short- and medium-term changes during recovery.
Study Setting and Population: This study includes adult patients diagnosed with colon cancer stages I to III, (TNM classification) who undergo surgical treatment at the Hospital Universitario Virgen de la Victoria in Málaga, Spain. Participants are identified and recruited before surgery through standard clinical pathways. All participants provide written informed consent before enrollment. The study is conducted in accordance with ethical principles and has been approved by the appropriate ethics committee.
Prehabilitation Phase (Preoperative Nutritional Care): Approximately two weeks before surgery, patients undergo a prehabilitation phase integrated into routine clinical care provided by the Endocrinology and Nutrition Department. This phase includes assessment and optimization of nutritional status through clinical evaluation, follow-up, and oral hypercaloric and hyperproteic supplementation when indicated. The aim is to improve metabolic condition and physiological reserve prior to surgical stress.
Surgical Treatment and Standard Postoperative Care: All participants undergo standard surgical treatment and postoperative oncological management according to institutional clinical practice. Participation in the study does not modify surgical procedures, immediate postoperative care, or oncological treatment.
Postoperative Interventions(Factorial Design): Approximately one month after surgery, once initial postoperative recovery has been achieved, participants enter the intervention phase (baseline visit). Participants are randomly assigned to one of four study groups according to a 2×2 factorial design:
- Standard nutritional care + general physical activity recommendations
- Standard nutritional care + supervised exercise program
- Enhanced nutritional supplementation (beta-hydroxy beta-methylbutyrate [HMB] and vitamin D) + general physical activity recommendations
- Enhanced nutritional supplementation (HMB and vitamin D) + supervised exercise program Enhanced nutritional supplementation consists of HMB combined with vitamin D (and calcium, when applicable), administered in addition to standard nutritional care.
The supervised physical activity program consists of structured, progressive resistance and functional exercises adapted to each participant's postoperative condition, targeting major muscle groups to improve muscle strength and functional capacity. Participants assigned to general physical activity receive standard recommendations according to routine clinical practice. Physical activity levels are objectively assessed using a wearable accelerometer.
Follow-up and Assessments: Approximately one month after surgery, once initial postoperative recovery has been achieved, participants enter the intervention and assessment phase (baseline visit) and are followed for approximately six months, with follow-up assessments at around 3 and 6 months. A comprehensive morphofunctional evaluation is performed at baseline and repeated at 6 months, including body composition, muscle strength, functional performance, and nutritional assessment using techniques such as bioelectrical impedance analysis, nutritional ultrasound, and standardized functional tests. Additional strength and resistance tests are also conducted as part of the study-specific evaluations. Biological samples (blood, urine, and stool) are collected at predefined time points to assess metabolic, inflammatory, and microbiota-related parameters. At the 3-month visit, a partial assessment is carried out, including selected clinical, functional, and questionnaire-based measures(including validated questionnaires assessing health status, quality of life, dietary intake, physical activity levels, and psychological well-being), allowing evaluation of both short- and medium-term changes during postoperative recovery. For participants assigned to the structured and supervised physical activity program, physical activity adherence, intensity, and patterns are objectively monitored using a wearable accelerometer, which is worn for 7 consecutive days monthly throughout the follow-up period, providing quantitative data on real-world physical activity behavior.
Study Relevance: By integrating perioperative nutritional care with structured postoperative interventions within a factorial design, the NIMA study aims to determine the independent and combined effects of nutritional supplementation and physical activity on recovery. The findings may contribute to optimizing perioperative care and improving functional outcomes in patients undergoing colon cancer surgery.
- Conditions
- Colon Cancer
- Being tested
- Standard hypercaloric-hyperproteic nutritional supplementation, HMB-enriched hypercaloric-hyperproteic nutritional supplementation with vitamin D and calcium, Supervised exercise program, General physical activity recommendations
- Keywords
- Colon cancer, Nutritional supplementation, Physical activity, Muscle strength, Inflammation, Gut microbiota, Beta-hydroxy beta-methylbutyrate supplementation, Vitamin D supplementation, Quality of life, Body composition
- Medical subject headings
- Colonic Neoplasms, Motor Activity, Inflammation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Standard hypercaloric-hyperproteic nutritional supplementationDietary supplement
Also called Standard Nutrition
Participants receive a standard oral nutritional supplementation consisting of a hypercaloric and hyperproteic formula designed to support recovery and nutritional status in patients undergoing surgery.
HMB-enriched hypercaloric-hyperproteic nutritional supplementation with vitamin D and calciumDietary supplement
Also called Enhanced Nutritional Supplementation
Participants receive an oral hypercaloric and hyperproteic nutritional supplementation enriched with β-hydroxy β-methylbutyrate (HMB) and supplemented with vitamin D and calcium. This formulation is designed to support muscle mass preservation and functional recovery in patients undergoing surgical treatment.
Supervised exercise programBehavioural
Also called Supervised Physical Activity
Participants follow a structured and supervised physical activity program including resistance exercises and functional training. Physical activity levels are periodically monitored using wearable activity devices.
General physical activity recommendationsBehavioural
Also called General Physical Activity
Participants receive general recommendations for physical activity according to routine clinical practice but do not participate in the structured supervised exercise program.
| Study group | Role | What they receive |
|---|---|---|
| Standard nutritional care + supervised exercise program | Experimental | Participants receive postoperative standard nutritional care according to routine clinical practice and individualized nutritional assessment. In addition, they participate in a structured supervised exercise program including progressive resistance and functional exercises targeting major muscle groups, adapted to their clinical condition. Receives: Dietary Supplement: Standard hypercaloric-hyperproteic nutritional supplementation; Behavioral: Supervised exercise program |
| Enhanced nutritional supplementation + non-structured physical activity | Experimental | Participants receive postoperative enhanced nutritional supplementation, including beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, in addition to standard nutritional care based on routine clinical practice and individualized nutritional assessment. Participants also receive general physical activity recommendations according to standard postoperative care without participation in a structured exercise program. Receives: Dietary Supplement: HMB-enriched hypercaloric-hyperproteic nutritional supplementation with vitamin D and calcium; Behavioral: General physical activity recommendations |
| Enhanced Nutritional Supplementation + Supervised Physical Activity | Experimental | Participants receive postoperative enhanced nutritional supplementation, including beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, in addition to standard nutritional care based on routine clinical practice and individualized nutritional assessment. In addition, they participate in a structured supervised exercise program including progressive resistance and functional exercises targeting major muscle groups, adapted to their clinical condition. Receives: Dietary Supplement: HMB-enriched hypercaloric-hyperproteic nutritional supplementation with vitamin D and calcium; Behavioral: Supervised exercise program |
| Standard nutritional care + general physical activity recommendations | Active comparator | Participants receive postoperative standard nutritional care according to routine clinical practice and individualized nutritional assessment. Participants also receive general physical activity recommendations according to standard postoperative care without participation in a structured exercise program. Receives: Dietary Supplement: Standard hypercaloric-hyperproteic nutritional supplementation; Behavioral: General physical activity recommendations |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in phase angle (PhA)
Phase angle will be assessed by bioelectrical impedance analysis (BIA) as a bioelectrical marker of nutritional and cellular status. Results will be expressed in degrees.
Measured: Baseline (first postoperative visit) and 6 months follow-up
Change in quadriceps rectus femoris cross-sectional area
Muscle mass will be assessed using nutritional ultrasound by measuring the cross-sectional area of the quadriceps rectus femoris at a standardized anatomical site (cm²).
Measured: Baseline (first postoperative visit) and 6 months follow-up
Secondary outcomes (5)
Plasma concentration of inflammatory and metabolic biomarkers measured by multiplex immunoassay
Plasma concentrations of selected biomarkers (including adiponectin, FABP-3, FGF-21, BDNF, IL-6, IL-15, TNF-α, and MCP-1) will be measured using multiplex immunoassay technology (Bio-Plex MAGPIX / Luminex xMAP). Each biomarker will be analyzed as an individual continuous variable and expressed in pg/mL.
Measured: From baseline (first postoperative visit), 3 months and 6 months follow-up
Percentage of DNA methylation in peripheral blood mononuclear cells (PBMCs)by quantitative PCR
DNA methylation levels will be assessed in peripheral blood mononuclear cells (PBMCs) using bisulfite conversion followed by quantitative PCR. Results will be expressed as the percentage of methylated cytosines at CpG sites.
Measured: Baseline (first postoperative visit) and 6 months follow-up
Change in urinary oxylipin concentrations by UHPLC-MS/MS
Selected oxylipins, including isoprostanes, prostaglandins, and thromboxane, will be quantified in first-morning urine samples using targeted ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-QqQ-MS/MS). Results will be expressed as concentrations normalized to urinary creatinine (e.g., ng/mg creatinine).
Measured: Baseline (first postoperative visit) and 6 months follow-up
Change in relative abundance of gut microbiota taxa
Gut microbiota composition will be assessed in stool samples using 16S rRNA gene sequencing. Relative abundance of bacterial taxa will be quantified at different taxonomic levels (e.g., phylum, genus) and expressed as percentages (%) of total sequencing reads per sample.
Measured: Baseline (first postoperative visit) and 6 months follow-up
Change in health-related quality of life score (EORTC QLQ-C30)
Health-related quality of life will be assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Scores will be calculated according to standard scoring procedures and expressed on a scale from 0 to 100.
Measured: Baseline (first postoperative visit), 3 months, and 6 months follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Apr 2026
- Study start1 Jul 2025
- Primary completionAug 2027 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Colon CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Model description
- Participants are assigned to one of four parallel study groups representing different combinations of nutritional supplementation and physical activity interventions during the postoperative period.
- Masking
- None (open label)
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- Sponsor type
- University, hospital or other
- Collaborators
- Instituto de Salud Carlos III
- Responsible party
- Sponsor
- Investigators
- Manuel Macías-Gonzalez, PhD, Principal investigator, Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)Carolina Muriel-Lopez, PhD, Principal investigator, Hospital Regional de Malaga
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07534852
- Sponsor's protocol ID
- NIMA
- Acronym
- NIMA
- Status last verified
- Apr 2026
- First submitted
- 20 Feb 2026
- Last updated
- 16 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: A decision regarding the sharing of individual participant data (IPD) has not yet been made. The study has received a favorable opinion from the relevant Research Ethics Committee. As described in the participant information and informed consent, data collected in this study are handled under strict confidentiality and in accordance with applicable data protection regulations, and are intended for research purposes within the scope of the project. If IPD is shared in the future, this would occur only in a de-identified format and upon reasonable request for scientific purposes.
Study at a glance
From the registry record, last updated by the sponsor on 16 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Nutritional, Inflammatory, and Muscular Assessment (NIMA) in Patients With Colon Cancer
- ClinicalTrials.gov ID
- NCT07534852
- Acronym / sponsor ID
- NIMA / NIMA
- Conditions
- Colon Cancer
- Keywords
- Colon cancer, Nutritional supplementation, Physical activity, Muscle strength, Inflammation, Gut microbiota, Beta-hydroxy beta-methylbutyrate supplementation, Vitamin D supplementation
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludUniversity, hospital or other
- Collaborators
- Instituto de Salud Carlos III
- Study start
- 1 Jul 2025 (actual)
- Primary completion
- Aug 2027 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 16 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to evaluate the effects of nutritional supplementation and physical activity interventions on recovery, muscle strength, nutritional status, inflammation, and metabolic health in adults with colon cancer undergoing surgery.
Patients with colon cancer frequently experience loss of muscle mass, reduced physical function, and nutritional deterioration both before and after surgery, which may adversely affect recovery and quality of life.
A key objective of this study is to assess whether a postoperative intervention combining nutritional supplementation with beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, together with a structured physical activity program, can improve muscle strength and functional recovery following colon cancer surgery.
This study aims to answer the following questions:
- Does nutritional supplementation with HMB and vitamin D, combined with postoperative physical activity, improve muscle strength and physical function following colon cancer surgery?
- How do nutritional and lifestyle interventions influence nutritional status, gut microbiota composition, and biological markers of inflammation and metabolism during the recovery period?
- Are there differences in recovery outcomes between patients receiving different types of nutritional support, with or without supervised physical activity?
Participants will be adults diagnosed with colon cancer who undergo surgical treatment at the Hospital Universitario Virgen de la Victoria in Málaga, Spain. Patients will be recruited prior to surgery and will enter a prehabilitation phase integrated into routine care provided by the Endocrinology and Nutrition Department.
During this prehabilitation phase, nutritional status will be assessed and optimized using standard clinical care, including oral nutritional supplementation when indicated. The aim is to improve the patient's condition before surgery. Approximately one month after surgery, once initial postoperative recovery has been completed, participants will enter the intervention and assessment phase (baseline visit).
Participants will then be randomly assigned to one of four study groups in a 2×2 factorial design. These groups combine two nutritional strategies (standard care or supplementation with HMB and vitamin D) and two physical activity approaches (supervised exercise or general activity recommendations). The physical activity component, supervised by the Endocrinology and Nutrition team, will be objectively evaluated using an accelerometer-based device. Participants will be followed for approximately six months, with assessments at about 3 and 6 months after the baseline visit.
At each visit, participants will undergo:
- Body composition measurements
- Muscle strength and physical performance tests
- Collection of blood, urine, and stool samples
- Questionnaires on health status and quality of life
The results of this study will contribute to a more profound understanding of how tailored nutritional strategies and postoperative physical activity may support recovery and functional health in patients undergoing surgery for colon cancer.
Detailed description
Colon cancer patients frequently present with nutritional impairment, systemic inflammation, and early loss of muscle mass even before surgical treatment. These conditions may be exacerbated by surgical stress, reduced intake, and postoperative physical inactivity, leading to delayed recovery, functional decline, and impaired quality of life. Interventions targeting nutritional and functional status across the perioperative period may help improve physiological reserve and support postoperative recovery.
The NIMA study (Nutritional, Inflammatory, and Muscular Assessment) is designed to evaluate the impact of perioperative nutritional care and postoperative physical activity strategies on recovery, muscle strength, nutritional status, inflammation, metabolic health, and gut microbiota in adults undergoing surgery for colon cancer. The study combines routine preoperative nutritional management with a structured postoperative intervention and follow-up period, allowing assessment of short- and medium-term changes during recovery.
Study Setting and Population: This study includes adult patients diagnosed with colon cancer stages I to III, (TNM classification) who undergo surgical treatment at the Hospital Universitario Virgen de la Victoria in Málaga, Spain. Participants are identified and recruited before surgery through standard clinical pathways. All participants provide written informed consent before enrollment. The study is conducted in accordance with ethical principles and has been approved by the appropriate ethics committee.
Prehabilitation Phase (Preoperative Nutritional Care): Approximately two weeks before surgery, patients undergo a prehabilitation phase integrated into routine clinical care provided by the Endocrinology and Nutrition Department. This phase includes assessment and optimization of nutritional status through clinical evaluation, follow-up, and oral hypercaloric and hyperproteic supplementation when indicated. The aim is to improve metabolic condition and physiological reserve prior to surgical stress.
Surgical Treatment and Standard Postoperative Care: All participants undergo standard surgical treatment and postoperative oncological management according to institutional clinical practice. Participation in the study does not modify surgical procedures, immediate postoperative care, or oncological treatment.
Postoperative Interventions(Factorial Design): Approximately one month after surgery, once initial postoperative recovery has been achieved, participants enter the intervention phase (baseline visit). Participants are randomly assigned to one of four study groups according to a 2×2 factorial design:
- Standard nutritional care + general physical activity recommendations
- Standard nutritional care + supervised exercise program
- Enhanced nutritional supplementation (beta-hydroxy beta-methylbutyrate [HMB] and vitamin D) + general physical activity recommendations
- Enhanced nutritional supplementation (HMB and vitamin D) + supervised exercise program Enhanced nutritional supplementation consists of HMB combined with vitamin D (and calcium, when applicable), administered in addition to standard nutritional care.
The supervised physical activity program consists of structured, progressive resistance and functional exercises adapted to each participant's postoperative condition, targeting major muscle groups to improve muscle strength and functional capacity. Participants assigned to general physical activity receive standard recommendations according to routine clinical practice. Physical activity levels are objectively assessed using a wearable accelerometer.
Follow-up and Assessments: Approximately one month after surgery, once initial postoperative recovery has been achieved, participants enter the intervention and assessment phase (baseline visit) and are followed for approximately six months, with follow-up assessments at around 3 and 6 months. A comprehensive morphofunctional evaluation is performed at baseline and repeated at 6 months, including body composition, muscle strength, functional performance, and nutritional assessment using techniques such as bioelectrical impedance analysis, nutritional ultrasound, and standardized functional tests. Additional strength and resistance tests are also conducted as part of the study-specific evaluations. Biological samples (blood, urine, and stool) are collected at predefined time points to assess metabolic, inflammatory, and microbiota-related parameters. At the 3-month visit, a partial assessment is carried out, including selected clinical, functional, and questionnaire-based measures(including validated questionnaires assessing health status, quality of life, dietary intake, physical activity levels, and psychological well-being), allowing evaluation of both short- and medium-term changes during postoperative recovery. For participants assigned to the structured and supervised physical activity program, physical activity adherence, intensity, and patterns are objectively monitored using a wearable accelerometer, which is worn for 7 consecutive days monthly throughout the follow-up period, providing quantitative data on real-world physical activity behavior.
Study Relevance: By integrating perioperative nutritional care with structured postoperative interventions within a factorial design, the NIMA study aims to determine the independent and combined effects of nutritional supplementation and physical activity on recovery. The findings may contribute to optimizing perioperative care and improving functional outcomes in patients undergoing colon cancer surgery.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- None (open label)
- Number of arms
- 4
- Model description
- Participants are assigned to one of four parallel study groups representing different combinations of nutritional supplementation and physical activity interventions during the postoperative period.
| Arm | Type | Receives |
|---|---|---|
| Standard nutritional care + supervised exercise program | Experimental | Dietary Supplement: Standard hypercaloric-hyperproteic nutritional supplementation, Behavioral: Supervised exercise programParticipants receive postoperative standard nutritional care according to routine clinical practice and individualized nutritional assessment. In addition, they participate in a structured supervised exercise program including progressive resistance and functional exercises targeting major muscle groups, adapted to their clinical condition. |
| Enhanced nutritional supplementation + non-structured physical activity | Experimental | Dietary Supplement: HMB-enriched hypercaloric-hyperproteic nutritional supplementation with vitamin D and calcium, Behavioral: General physical activity recommendationsParticipants receive postoperative enhanced nutritional supplementation, including beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, in addition to standard nutritional care based on routine clinical practice and individualized nutritional assessment. Participants also receive general physical activity recommendations according to standard postoperative care without participation in a structured exercise program. |
| Enhanced Nutritional Supplementation + Supervised Physical Activity | Experimental | Dietary Supplement: HMB-enriched hypercaloric-hyperproteic nutritional supplementation with vitamin D and calcium, Behavioral: Supervised exercise programParticipants receive postoperative enhanced nutritional supplementation, including beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, in addition to standard nutritional care based on routine clinical practice and individualized nutritional assessment. In addition, they participate in a structured supervised exercise program including progressive resistance and functional exercises targeting major muscle groups, adapted to their clinical condition. |
| Standard nutritional care + general physical activity recommendations | Active comparator | Dietary Supplement: Standard hypercaloric-hyperproteic nutritional supplementation, Behavioral: General physical activity recommendationsParticipants receive postoperative standard nutritional care according to routine clinical practice and individualized nutritional assessment. Participants also receive general physical activity recommendations according to standard postoperative care without participation in a structured exercise program. |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Adults aged 18 to 75 years.
- Male and female participants.
- Diagnosis of colon cancer at localized or locally advanced stages (TNM stages I-III).
- Patients scheduled for primary surgical treatment.
Key exclusion criteria (11 listed)
- Metastatic disease (stage IV)
- Diagnosis of rectal cancer or tumors involving the rectum
- Prior neoadjuvant chemotherapy or radiotherapy before surgery.
- Presence of synchronous malignant tumors.
- Pregnant or breastfeeding women.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Standard hypercaloric-hyperproteic nutritional supplementationAlso: Standard NutritionParticipants receive a standard oral nutritional supplementation consisting of a hypercaloric and hyperproteic formula designed to support recovery and nutritional status in patients undergoing surgery. | Dietary supplement | Standard nutritional care + general physical activity recommendations, Standard nutritional care + supervised exercise program |
| HMB-enriched hypercaloric-hyperproteic nutritional supplementation with vitamin D and calciumAlso: Enhanced Nutritional SupplementationParticipants receive an oral hypercaloric and hyperproteic nutritional supplementation enriched with β-hydroxy β-methylbutyrate (HMB) and supplemented with vitamin D and calcium. This formulation is designed to support muscle mass preservation and functional recovery in patients undergoing surgical treatment. | Dietary supplement | Enhanced Nutritional Supplementation + Supervised Physical Activity, Enhanced nutritional supplementation + non-structured physical activity |
| Supervised exercise programAlso: Supervised Physical ActivityParticipants follow a structured and supervised physical activity program including resistance exercises and functional training. Physical activity levels are periodically monitored using wearable activity devices. | Behavioural | Enhanced Nutritional Supplementation + Supervised Physical Activity, Standard nutritional care + supervised exercise program |
| General physical activity recommendationsAlso: General Physical ActivityParticipants receive general recommendations for physical activity according to routine clinical practice but do not participate in the structured supervised exercise program. | Behavioural | Enhanced nutritional supplementation + non-structured physical activity, Standard nutritional care + general physical activity recommendations |
Primary outcome
Change in phase angle (PhA)
Time frame: Baseline (first postoperative visit) and 6 months follow-up
Phase angle will be assessed by bioelectrical impedance analysis (BIA) as a bioelectrical marker of nutritional and cellular status. Results will be expressed in degrees.
Change in quadriceps rectus femoris cross-sectional area
Time frame: Baseline (first postoperative visit) and 6 months follow-up
Muscle mass will be assessed using nutritional ultrasound by measuring the cross-sectional area of the quadriceps rectus femoris at a standardized anatomical site (cm²).
5 secondary outcomes
Plasma concentration of inflammatory and metabolic biomarkers measured by multiplex immunoassay
Time frame: From baseline (first postoperative visit), 3 months and 6 months follow-up
Percentage of DNA methylation in peripheral blood mononuclear cells (PBMCs)by quantitative PCR
Time frame: Baseline (first postoperative visit) and 6 months follow-up
Change in urinary oxylipin concentrations by UHPLC-MS/MS
Time frame: Baseline (first postoperative visit) and 6 months follow-up
Change in relative abundance of gut microbiota taxa
Time frame: Baseline (first postoperative visit) and 6 months follow-up
Change in health-related quality of life score (EORTC QLQ-C30)
Time frame: Baseline (first postoperative visit), 3 months, and 6 months follow-up
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Apr 2026.
- Individual participant dataSharing planned: Undecided. A decision regarding the sharing of individual participant data (IPD) has not yet been made. The study has received a favorable opinion from the relevant Research Ethics Committee. As described in the participant information and informed consent, data collected in this study are handled under strict confidentiality and in accordance with applicable data protection regulations, and are intended for research purposes within the scope of the project. If IPD is shared in the future, this would occur only in a de-identified format and upon reasonable request for scientific purposes.
Related trials for Colon Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Toripalimab Plus Cetuximab and Irinotecan for Second-Line Right-Sided RAS/BRAF Wild-Type Advanced Colon Cancer Phase II Study
Colorectal Cancer (CRC)
Not yet recruiting
FLuorescent Angiography in REduction of Anastomotic Leak in Rectal Cancer Surgery
Rectal Cancer Patients, Rectal Cancer Surgery
Not yet recruiting
A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
NSCLC (Advanced Non-small Cell Lung Cancer), NSCLC (Non-small Cell Lung Cancer)
Not yet recruitingPhase 1
A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors
Advanced Breast Cancer, Advanced or Metastatic Breast Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Manuel Macías-Gonzalez, PhD principal investigator
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
Carolina Muriel-Lopez, PhD principal investigator
Hospital Regional de Malaga
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Standard hypercaloric-hyperproteic nutritional supplementation, HMB-enriched hypercaloric-hyperproteic nutritional supplementation with vitamin D and calcium and Supervised exercise program in people with Colon Cancer, run by Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 16 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Manuel Macías-González, PhD. (+34 952 36 76 00, mmacias.manuel@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in phase angle (PhA) (time frame: Baseline (first postoperative visit) and 6 months follow-up). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2026.